Anivive begins two pre-clinical studies of GC376 for the treatment of COVID-19

PolyPid begins first phase three clinical trial of D-PLEX100

US FDA grants Orphan Drug Designation to ISA Pharmaceuticals' ISA101b

Affinity discovers potent antibodies that can completely neutralize SARS-CoV-2 infection

GoldenBiotech wins FDA approval to begin Phase 2 trial of Antroquinonol in COVID-19 patients in the US

Gravity Diagnostics announces Kroger Health's home collection kit to expand COVID-19 testing

Sherlock Biosciences, binx health Partner to Develop First CRISPR-based Point-of-care Test for COVID-19

Meissa Vaccines Provides a Pipeline Update on Vaccine Candidates for COVID-19 and RSV

Mezzion Pharma submits New Drug Application to US FDA for Udenafil

US FDA, FTC Warn Companies to Stop Selling Unapproved COVID-19 Products

Beckman Coulter's SARS-CoV-2 IgG antibody test wins FDA's EUA

Luminex submits EUA with FDA for xMAP SARS-CoV-2 Multi-Antigen IgG assay to detect antibodies in patients

US FDA approves SFA Therapeutics' clinical trial for treatment of 'the appearance of the structure of skin with plaques due to psoriasis'

Cytocom Completes Type-B Pre-IND Meeting with FDA Regarding Proposed Phase 2 Clinical Trial of CYTO-201 in COVID-19 Patients

The European Commission approves Bristol Myers Squibb's and Acceleron Pharma's Reblozyl